Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703

Prof Jorge Riera-Knorrenschild - University Clinic Giessen and Marburg, Marburg, Germany
Maintenance therapy of metastatic colorectal carcinoma with the TLR-9 agonist MGN1703 ( Prof Jorge Riera-Knorrenschild - University Clinic Giessen and Marburg, Marburg, Germany )
25 Mar 2014

Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes

Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark
Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes ( Prof Inge Marie Svane - Herlev Hospital, Copenhagen University, Copenhagen, Denmark )
25 Mar 2014

The 1st Immunotherapy of Cancer Conference (ITOC)

Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria
The 1st Immunotherapy of Cancer Conference (ITOC) ( Prof Heinz Zwierina - Innsbruck Medical University, Innsbruck, Austria )
25 Mar 2014

Reasons for combining immunotherapy with chemo to enhance anti tumour response

Prof Angus Dalgleish - St George's, University of London, London, UK
Reasons for combining immunotherapy with chemo to enhance anti tumour response ( Prof Angus Dalgleish - St George's, University of London, London, UK )
25 Mar 2014

High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology

Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands
High-affinity CD20-specific TCRs suitable for adoptive immunotherapy isolated from the allo-repertoire using reverse immunology ( Dr Lorenz Jahn - Leiden Univeristy Medical Centre, Leiden, The Netherlands )
25 Mar 2014

Molecular pathways associated with immune modulation and thalidomide analogues

Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene
Molecular pathways associated with immune modulation and thalidomide analogues ( Dr Rajesh Chopra - Vice President of Translational and Early Drug Development, Celgene )
25 Mar 2014

Dendritic cell vaccination combined with CTLA4 blockade

Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium
Dendritic cell vaccination combined with CTLA4 blockade ( Dr Kris Thielemans - Medical School of the VUB, Brussels, Belgium )
25 Mar 2014

Immuno-biological properties of human cancer stem cells

Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena, Italy
Immuno-biological properties of human cancer stem cells ( Dr Cristina Maccalli - NIBIT (Italian Network for Biotherapy of Tumours), Siena, Italy )
24 Mar 2014

Cost constraints affect treatment decision-making in China and Singapore - expert discussion

Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran
Cost constraints affect treatment decision-making in China and Singapore - expert discussion ( Prof Kurt Miller, Dr Li-qun Zhou and Dr Ravindran Kanesvaran )
21 Mar 2014

ecancermedicalscience Editor's Choice for January 2014

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
ecancermedicalscience Editor's Choice for January 2014 ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
12 Feb 2014

Preventing metastases by tackling exosomes

Dr Jeff Wrana - University of Toronto, Canada
Preventing metastases by tackling exosomes ( Dr Jeff Wrana - University of Toronto, Canada )
19 Dec 2013

Moving breast cancer stem cell therapies to the clinic

Dr Max Wicha - University of Michigan, Ann Arbor, USA
Moving breast cancer stem cell therapies to the clinic ( Dr Max Wicha - University of Michigan, Ann Arbor, USA )
19 Dec 2013